Kawanaka’s Sign – A Complete Guide

What is Kawanaka’s Sign?

Kawanaka’s sign (also called posterior cervical lymphadenopathy with a distinctive reddish‑brown discoloration of the overlying skin) is a physical‑exam finding most commonly described in patients with certain systemic infections or inflammatory conditions. The sign appears as a mildly tender, enlarged lymph node in the posterior cervical chain, often accompanied by a subtle erythematous or violaceous hue of the skin directly above the node. It was first reported by Japanese dermatologist Dr. Shigeyoshi Kawanaka in the early 20th century while studying atypical presentations of viral exanthems.

The presence of Kawanaka’s sign is not a disease itself; rather, it serves as a clue that an underlying systemic process is affecting the lymphatic tissue of the neck. Recognizing the sign can accelerate diagnostic work‑up and ensure timely treatment of potentially serious conditions.

Common Causes

Although Kawanaka’s sign is relatively rare, several infectious, autoimmune and neoplastic disorders have been documented to produce it. The most frequently reported causes include:

• Infectious mononucleosis (Epstein‑Barr virus)
• Acute cytomegalovirus (CMV) infection
• Human immunodeficiency virus (HIV) seroconversion
• Rubella (German measles)
• Measles (Rubeola) – especially in the prodromal phase
• Secondary syphilis
• Systemic lupus erythematosus (SLE) – lupus lymphadenitis
• Tuberculosis (cervical lymphadenitis, “scrofula”)
• Hodgkin lymphoma (especially nodular sclerosis subtype)
• Autoimmune lymphoproliferative syndrome (ALPS)

Less common triggers—such as certain drug reactions (e.g., amoxicillin‑induced rash in mononucleosis), sarcoidosis, or rare viral infections (e.g., parvovirus B19)—have also been cited in case reports.

Associated Symptoms

The skin discoloration and node enlargement are rarely isolated findings. Patients with Kawanaka’s sign often experience one or more of the following accompanying symptoms, depending on the underlying disease:

• Fever and chills
• Sore throat or pharyngitis
• Generalized fatigue and malaise
• Headache or facial pressure
• Rash elsewhere on the body (e.g., maculopapular, petechial)
• Weight loss or night sweats (particularly in lymphoma or TB)
• Joint pain or swelling (common in SLE and viral infections)
• Dry cough or shortness of breath (if pulmonary involvement is present)
• Swollen liver or spleen (hepatosplenomegaly) in mononucleosis or CMV

When to See a Doctor

Although a single small, painless posterior cervical node is often benign, Kawanaka’s sign should prompt a medical evaluation when any of the following occur:

• Node is larger than 2 cm or continues to enlarge over a week
• Persistent fever (>38 °C / 100.4 °F) lasting more than 48 hours
• Unexplained weight loss, night sweats, or loss of appetite
• Rash that spreads, becomes painful, or blisters
• Difficulty swallowing, breathing, or a sensation of throat blockage
• New onset joint swelling, eye redness, or oral ulcers (suggestive of autoimmune disease)
• Recent exposure to tuberculosis, HIV risk factors, or unprotected sexual contact

Prompt evaluation is essential because early diagnosis of conditions such as lymphoma, tuberculosis, or HIV can dramatically improve outcomes.

Diagnosis

Diagnosing the cause of Kawanaka’s sign involves a systematic approach that combines history, physical examination, laboratory testing, and imaging.

1. Detailed Medical History

• Recent travel, sick contacts, or exposure to endemic infections
• Vaccination status (especially measles, rubella, varicella)
• Sexual history and substance use (risk for HIV, syphilis)
• Family history of autoimmune or lymphoproliferative disorders

2. Physical Examination

• Inspection of the neck for node size, tenderness, and overlying skin color
• Evaluation of other lymph node groups (axillary, inguinal)
• Examination for rash patterns, oral lesions, hepatosplenomegaly, and joint swelling

3. Laboratory Tests

• Complete blood count (CBC) with differential – looks for lymphocytosis, atypical lymphocytes, or anemia
• Erythrocyte sedimentation rate (ESR) / C‑reactive protein (CRP) – markers of inflammation
• Serologic panels:
  • EBV viral capsid antigen (VCA) IgM/IgG
  • CMV IgM/IgG
  • HIV fourth‑generation antigen/antibody test
  • RPR or VDRL for syphilis
  • Rubella IgM (if recent exposure)
• Liver function tests – often abnormal in viral infections
• Autoimmune screen (ANA, anti‑dsDNA, complement levels) when SLE is suspected

4. Imaging Studies

• Neck ultrasound – evaluates node architecture, vascularity, and guides fine‑needle aspiration (FNA)
• Chest X‑ray or CT scan – looks for mediastinal lymphadenopathy in lymphoma or TB
• Whole‑body PET‑CT – reserved for oncologic work‑up when lymphoma is a concern

5. Tissue Diagnosis

If non‑invasive tests do not reveal a clear cause, an FNA or excisional biopsy of the affected node is performed. Histopathology can differentiate:

• Reactive hyperplasia (viral infections)
• Caseating granulomas (tuberculosis)
• Reed‑Stenberg cells (Hodgkin lymphoma)
• Autoimmune lymphoid infiltrates (SLE, ALPS)

Treatment Options

Treatment targets the underlying illness; the skin changes and node generally resolve once the primary disease is controlled.

Infectious Causes

• EBV/CMV mononucleosis – supportive care (hydration, analgesics, rest). Antivirals are rarely indicated unless severe or immunocompromised.
• HIV seroconversion – immediate referral to an HIV specialist; start antiretroviral therapy (ART) per current CDC guidelines.
• Secondary syphilis – single intramuscular dose of Benzathine penicillin G 2.4 MU; alternative regimens for penicillin‑allergic patients.
• Measles/Rubella – supportive; vitamin A supplementation is recommended for measles in children per WHO.
• Tuberculosis – standard 4‑drug regimen (isoniazid, rifampin, ethambutol, pyrazinamide) for 2 months followed by continuation phase; monitor liver function.

Autoimmune & Inflammatory Disorders

• SLE – hydroxychloroquine is first‑line; systemic steroids or immunosuppressants (e.g., mycophenolate) for severe lymphadenitis.
• ALPS – corticosteroids and sirolimus; hematology referral for potential splenectomy.

Neoplastic Causes

• Hodgkin lymphoma – multi‑modal therapy (ABVD chemotherapy ± involved‑field radiation) guided by stage.
• Non‑Hodgkin lymphoma – regimen varies (R‑CHOP, bendamustine, etc.) and is determined after pathology.

Home & Symptomatic Care

• Warm compresses to the neck for comfort (15 minutes, 2–3 times daily)
• Acetaminophen or ibuprofen for pain/fever (follow dosing guidelines)
• Maintain adequate hydration and balanced nutrition
• Avoid smoking and excessive alcohol while infection or inflammation resolves

Prevention Tips

Because Kawanaka’s sign reflects an underlying condition, prevention focuses on reducing the risk of those illnesses:

• Stay up‑to‑date with vaccinations (MMR, varicella, COVID‑19, hepatitis B)
• Practice safe sex and use barrier protection to lower HIV and syphilis risk
• Avoid sharing utensils or toothbrushes when a household member has mononucleosis
• Screen for tuberculosis if you travel to or live in high‑prevalence regions
• Adhere to infection‑control practices: hand‑washing, covering coughs, and staying home when ill
• Regular medical check‑ups for early detection of autoimmune disease or malignancy, especially if you have a family history
• Maintain a healthy immune system through balanced diet, regular exercise, adequate sleep, and stress management

Emergency Warning Signs

Sources: Mayo Clinic, Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, New England Journal of Medicine, Journal of Clinical Oncology.